These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3919652)

  • 41. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Ro ribonucleoprotein particle: induction of autoantibodies and the detection of Ro RNAs among species.
    Mamula MJ; O'Brien CA; Harley JB; Hardin JA
    Clin Immunol Immunopathol; 1989 Sep; 52(3):435-46. PubMed ID: 2503280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein.
    Itoh Y; Reichlin M
    Autoimmunity; 1992; 14(1):57-65. PubMed ID: 1284379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice.
    Lee LA; Gaither KK; Coulter SN; Norris DA; Harley JB
    J Clin Invest; 1989 May; 83(5):1556-62. PubMed ID: 2651477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunologically restricted and inhibitory anti-Ro/SSA in monozygotic twins.
    Scofield RH; Kurien BT; Reichlin M
    Lupus; 1997; 6(4):395-8. PubMed ID: 9175026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjögren's syndrome.
    Cho CS; Park SH; Min JK; Lee SH; Kim HY
    Korean J Intern Med; 1997 Jun; 12(2):176-81. PubMed ID: 9439152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and clinical significance of antibodies to ribonucleoproteins in systemic lupus erythematosus in Malaysia.
    Wang CL; Ooi L; Wang F
    Br J Rheumatol; 1996 Feb; 35(2):129-32. PubMed ID: 8612023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sialographic study in patients with and without antibodies to Sjögren's syndrome A (Ro).
    Miyachi K; Naito M; Maeno Y; Suzuki S; Hamamoto T; Sugiura M; Kasahara M; Torikai K; Umeda H
    J Rheumatol; 1983 Jun; 10(3):387-94. PubMed ID: 6604159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Female predominance of immune response to SSA/Ro antigens and risk of neonatal lupus erythematosus.
    Miyagawa S; Dohi K; Yoshioka A; Shirai T
    Br J Dermatol; 1990 Aug; 123(2):223-7. PubMed ID: 2400724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A shared idiotype among human anti-Ro/SSA autoantibodies.
    Gaither KK; Harley JB
    J Exp Med; 1989 May; 169(5):1583-8. PubMed ID: 2469761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus.
    Verdelli A; Coi A; Marzano AV; Antiga E; Cozzani E; Quaglino P; La Placa M; Benucci M; De Simone C; Papini M; Parodi A; Bianchi F; Caproni M
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):742-752. PubMed ID: 29924416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
    Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
    Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus.
    Harley JB; Scofield RH; Reichlin M
    Rheum Dis Clin North Am; 1992 May; 18(2):337-58. PubMed ID: 1626073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract.
    Eisenberg RA
    J Immunol; 1985 Sep; 135(3):1707-13. PubMed ID: 2410502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of anti-Ro/Sjögren's syndrome A antigen autoantibody in normal sera for autoimmunity.
    Gaither KK; Fox OF; Yamagata H; Mamula MJ; Reichlin M; Harley JB
    J Clin Invest; 1987 Mar; 79(3):841-6. PubMed ID: 3546381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies reactive with small ribonucleoprotein antigens: a convergence of molecular biology and clinical immunology.
    McNeilage LJ; Whittingham S; Mackay IR
    J Clin Lab Immunol; 1984 Sep; 15(1):1-17. PubMed ID: 6210367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detection of SSA/Ro antibody in patients with systemic lupus erythematosus, discoid lupus erythematosus and cutaneous photosensitivity. A comparative study].
    Carazzai AM; Sucena RC; Milano SI; Munhoz EG; Santos RA; Scheinberg MA
    Rev Paul Med; 1988; 106(2):71-4. PubMed ID: 3148992
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis.
    Boire G; Ménard HA
    J Rheumatol; 1988 Mar; 15(3):391-4. PubMed ID: 3259983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients.
    Frank MB; McArthur R; Harley JB; Fujisaku A
    J Clin Invest; 1990 Jan; 85(1):33-9. PubMed ID: 1967259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
    Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.